Healthcare chief execs at 177 top companies collectively saw their compensation grow to $2.6 billion last year while quality of care and improvements to healthcare spending remained at most a marginal factor to their pay, according to an Axios analysis. Despite a focus on pharmaceutical CEOs, medical device company chief execs were five of the […]
Edwards adds $1B to share repurchase program
Edwards Lifesciences (NYSE:EW) said that its board of directors authorized an additional $1 billion for stock repurchases, according to a recently posted SEC filing. The Irvine, Calif.-based company said that with the additional allocation, it now has a total of $1.3 billion remaining under its share repurchase program. In the same SEC filing, the company also […]
UK court shoots down Abbott bid for injunction in TMVR patent spat with Edwards
Edwards Lifesciences (NYSE:EW) recently claimed a win in a UK-based patent spat with Abbott (NYSE:ABT) over IP related to each company’s respective transcatheter mitral valve repair devices after a UK court shot down a bid from Abbott for a preliminary injunction. In the suit, filed on January 28, Abbott claimed that Edwards is infringing on two of […]
FDA: Edward’s select recall of Miller, Fogarty atrioseptostomy caths is Class I
The FDA has classified a select recall of Edwards Lifesciences (NYSE:EW) Miller and Fogarty atrioseptostomy catheters over balloon deflation, fragmentation and detachment issues as Class I. Class I designations, the FDA’s most severe, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The Miller Balloon catheter […]
Edwards Lifesciences post Street-beating Q1 earnings
Shares in Edwards Lifesciences (NYSE:EW) fell slightly today despite the medical device maker posting Street-beating first quarter earnings results that saw the growth on the bottom line of over 20%. The Irvine, Calif.-based company posted profits of $249.7 million, or $1.18 per share, on sales of $993 million for the three months ended March 31, for […]
Edwards Lifesciences closes $98m CAS Medical Systems buyout
Edwards Lifesciences (NYSE:EW) yesterday closed the $98 million acquisition of CAS Medical Systems and its non-invasive brain tissue oxygenation monitoring tech. Irvine, Calif.-based Edwards paid $2.45 per share for Branford, Conn.-based Casmed using cash on hand, for an aggregate value of $98.1 million, Casmed said in a regulatory filing. The deal was announced Feb. 12. The […]
Neovasc settles final spat with Edwards unit CardiAQ Valve
Neovasc (NSDQ:NVCN) said late yesterday that it resolved the last remaining patent litigation between it and Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies by adding members of CardiAQ as co-inventors of the patents in dispute. Vancouver-based Neovasc said that it added CardiAQ’s Jeremy Brent Ratz and Arshad Quadri as co-inventors of three patents, each of which was related […]
Mick Jagger is giving TAVR a boost: Here’s how
A successful transcatheter aortic valve replacement (TAVR) recovery for rock icon Mick Jagger could be good news for companies such as Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) that make devices for the procedure, according to analysts following the medical device industry. The Rolling Stone frontman tweeted Friday that he was feeling better and on the […]
Edwards Lifesciences doubles down on Irish plant
Edwards Lifesciences (NYSE:EW) reportedly plans to double its investment in a plant it’s building in Ireland that’s expected to add 600 jobs to the local economy. Last year the Irvine, Calif.-based company said it planned to build a new, 170,000-square-foot facility in Limerick to manufacture delivery components for its transcatheter heart valves. At the time the […]
Neovasc claims win in German TMVR patent case against Edwards unit CardiAQ Valve
Neovasc (NSDQ:NVCN) today claimed a win in its patent infringement war with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies, saying a German appeals court dismissed a case there. In June 2017 the District Court in Munich ruled that CardiAQ Valve contributed to the creation of Neovasc’s Tiara transcatheter mitral valve replacement, awarding”co-entitlement” rights to the patent in […]
ACC 2019: Medtronic, Edwards low-risk TAVR trial data could pave way to new indications
Results from trials of both Medtronic‘s (NYSE:MDT) and Edwards Lifesciences‘ (NYSE:EW) transcatheter aortic valve replacement systems exploring their use in low-risk patients indicated that the devices were as safe as open surgery, paving the way for possible new indications for TAVR technology. Data from the trials were presented over the weekend at the American College […]
- 1
- 2
- 3
- …
- 41
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube